Tissue distribution of major matrix metalloproteinases and their transcripts in human breast carcinomas

Anticancer Research

Volumn 19, Issue 5 B, 1999, Pages 4257-4264

  Lebeau, A ^a   Nerlich, Andreas G ^a   Sauer, U ^a   Lichtinghagen, R ^b   Lohrs U ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Basement membrane; Breast carcinoma; Matrix metalloproteinases

Indexed keywords

ANTIBODY; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MESSENGER RNA; PROTEINASE; STROMELYSIN;

ARTICLE; BASEMENT MEMBRANE; BREAST CARCINOMA; CARCINOMA; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; STROMA CELL; TISSUE DISTRIBUTION;

BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CYTOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; RNA, MESSENGER; TISSUE DISTRIBUTION;

EID: 0032787542     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Nerlich A: Wert der Basalmembrandarstellung in der Diagnostik invasiver Karzinome. Pathologe 19: 89-94, 1998.
2. Nerlich A, Haraida S, Hagedorn H, Wiest I, Schreiner M, Schleicher ED: Morphological aspects of basement membranes and their receptors in benign and malignant neoplasms. Int J Oncol 6: 1193-1202, 1995.
3. Albrechtsen R, Nielson M, Wewer U, Engvall E, Ruoslahti E: Basement membrane changes in breast cancer detected by immunohistochemical staining for laminin. Cancer Res 41: 5076-5081, 1981.
4. Remberger K, Nerlich A: Diagnostischer Wert der Darstellung von Basalmembranproteinen in benignen und malignen Mammaveranderungen. Verh Dtsch Ges Pathol 69: 123-130, 1985.
5. Wetzels RHW, Holland R, van Haelst JGM, Lane B, Ramaekers FCS: Detection of basement membrane components and basal cell keratin 14 in noninvasive and invasive carcinomas of the breast. Am J Pathol 134: 571-579, 1989 .
6. Nerlich AG, Lebeau A, Hagedorn H, Sauer U, Schleicher ED: Morphological aspects of altered basement membrane metabolism in invasive carcinomas of the breast and the larynx. Anticancer Res 18: 3515-3520, 1998.
7. Soini Y, Hurskainen T, Höyhtyä M, Oikarinen A, Autio-Harmainen H: 72 kd and 92 kd type IV collagenase, type IV collagen and laminin mRNAs in breast cancer: A study by in situ hybridization. J Histochem Cytochem 42: 945-951, 1994.
8. Clavel C, Doco M, Lallemand A, Laurent M, Birembaut P: Detection by in situ hybridization of messenger RNAs of collagen types I and IV in murine mammary cancer. Int J Cancer 44: 548-553, 1989.
9. Stetler-Stevenson WG, Liotta LA, Kleiner DE: Role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J 7: 1434-1441, 1993.
10. Daher N, Abourachid H, Bove N, Petit J, Burtin P: Collagen IV staining pattern in bladder carcinomas: relationship to prognosis. Br J Cancer 55: 665-671, 1987.
11. Offerhaus GJA, Giardiello FM, Brujin JA, Stjinen T, Molyvas EN, Fleuren GJ: The value of immunohistochemistry for collagen IV expression in colorectal carcmomas. Cancer 67: 99-105, 1991.
12. Heppner KJ, Matrisian LM, Jensen RA, Rodgers WH: Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol 149: 273-282, 1996.
13. McDougall JR, Matrisian LM: Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev 14: 351-362, 1995.
14. Hoyhtya M, Fridman R, Komarek D, Porter-Jordan K, Stetler-Stevenson WG, Liotta LA, Liang CM: Immunohistochemical localization of matrix metalloproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissues with monoclonal antibody. Int JCancer 56: 500-505, 1994.
15. Polette M, Gilbert N, Stas I, Nawrocki B, Noel A, Remacle A, Stetler-Stevenson WG, Birembaut P, Foidart M: Gelatinase A expression and localization in human breast cancer. An in situ hybridisation study and immunohistochemical detection using confocal microscopy. Virchows Arch 424: 641-645, 1994.
16. Lichtinghagen R, Helbrecht T, Arndt B, Boker KHW: Expression of matrix metalloproteinases in human liver. Eur J Clin Chem Clin Biochem 33: 65-71, 1995.
17. Schleicher E, Wagner EM, Olgemoller B, Nerlich A, Gerbitz KD: Characterization and localisation of basement membrane associated heparan sulfate proteoglycan in human tissues. Lab Invest 61: 323-332, 1989.
18. Nerlich A, Schleicher E: Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions. Am J Pathol 139: 889-899, 1991.
19. Ceol M, Nerlich A, Baggio B, Anglani F, Sauer U, Schleicher E, Gambaro G Increased glomerular al(IV) collagen expression and deposition in long-term diabetic rats is prevented by chronic glycosaminoglycan treatment. Lab Invest 74: 484-495, 1996.
20. Cordell JL, Falini B, Erber WN, Ghosh AH, Abdulaziz Z, MacDonald S, Pulford AF, Stein H, Mason DY: Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase. J Histochem Cytochem 32: 219-225, 1984.
21. Barsky SH, Siegal GP, Jannotta F, Liotta LA: Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Invest 49: 140-147, 1983.
22. Aznavoonan S, Murphy AN, Stetler-Stevenson WG, Liotta LA: Molecular aspects of tumor cell invasion and metastasis. Cancer 71: 1368-1383, 1993.
23. Li F, Strange R, Friis RR, Djonov V, Altermatt HJ, Saurer S, Niemann H, Andres AC: Expression of stromelysin-1 and TIMP-1 in the involving mammary gland and in invasive tumors of the mouse. Int J Cancer 15: 560-568, 1994.
24. Boag AH, Young ID: Increased expression of the 72kDa type IV collagenase in prostatic adenocarcinoma. Am J Pathol 144: 585-591, 1994.
25. Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T, Neal D, Thomas D, Hanby A, Balkvill F: Levels of matrix metalloproteinases in bladder cancer correlate with tumor grade and invasion. Cancer Res 53: 5365-5369, 1993.
26. Zeng ZS, Guillem JG: Distinct pattern of matrix metallo-proteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastasis. Br J Cancer 72: 575-582, 1995.